[Federal Register Volume 79, Number 17 (Monday, January 27, 2014)]
[Notices]
[Page 4341]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-01441]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning Plasmodium 
Falciparum Circumsporozoite Vaccine Gene Optimization for Soluble 
Protein Expression

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Patent Application Serial No. 13/880,227, 
entitled ``Plasmodium Falciparum Circumsporozoite Vaccine Gene 
Optimization for Soluble Protein Expression,'' filed on June 11, 2013. 
The United States Government, as represented by the Secretary of the 
Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to a method to produce 
vaccine grade, highly immunogenic and near full-length CSP of P. 
falciparum in E. coli.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-01441 Filed 1-24-14; 8:45 am]
BILLING CODE 3710-08-P